Vertex Pharmaceuticals Stock Forecast - Daily Balance Of Power
VX1 Stock | EUR 441.80 3.80 0.87% |
Vertex Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Vertex Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Vertex |
Check Vertex Pharmaceuticals Volatility | Backtest Vertex Pharmaceuticals | Trend Details |
Vertex Pharmaceuticals Trading Date Momentum
On September 10 2024 Vertex Pharmaceuticals Incorporated was traded for 425.85 at the closing time. The highest daily price throughout the period was 425.85 and the lowest price was 425.85 . There was no trading activity during the period 3.0. Lack of trading volume on 09/10/2024 added to the next day price rise. The trading price change to closing price of the next trading day was 0.97% . The trading price change to current closing price is 3.45% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Vertex Pharmaceuticals to competition |
Other Forecasting Options for Vertex Pharmaceuticals
For every potential investor in Vertex, whether a beginner or expert, Vertex Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Vertex Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Vertex. Basic forecasting techniques help filter out the noise by identifying Vertex Pharmaceuticals' price trends.Vertex Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vertex Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Vertex Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Vertex Pharmaceuticals by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Vertex Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Vertex Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Vertex Pharmaceuticals' current price.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Vertex Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Vertex Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vertex Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Vertex Pharmaceuticals stock market strength indicators, traders can identify Vertex Pharmaceuticals Incorporated entry and exit signals to maximize returns.
Vertex Pharmaceuticals Risk Indicators
The analysis of Vertex Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Vertex Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting vertex stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 1.3 | |||
Semi Deviation | 1.43 | |||
Standard Deviation | 1.89 | |||
Variance | 3.57 | |||
Downside Variance | 2.16 | |||
Semi Variance | 2.04 | |||
Expected Short fall | (1.64) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Other Information on Investing in Vertex Stock
Vertex Pharmaceuticals financial ratios help investors to determine whether Vertex Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vertex with respect to the benefits of owning Vertex Pharmaceuticals security.